RAPT Therapeutics Inc (RAPT)
7.93
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 16:00
7.93
0.00 (0.00%)
After-Hours: 17:57
RAPT Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Date | Value |
---|---|
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
--
Maximum
Mar 2020
--
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
Emergent BioSolutions Inc | 1.325 |
Avinger Inc | -2.305 |
Skye Bioscience Inc | -- |
Axsome Therapeutics Inc | 0.9324 |
Vaccinex Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 173.33M |
Total Liabilities (Quarterly) | 26.29M |
Shareholders Equity (Quarterly) | 147.04M |